Many brand protection programs focus on the latest in packaging and tracking technologies. Its simply not enough to stop there: pharmaceutical product will continue to be counterfeited and/or escape the supply chain, even with these kind of controls.
Protection of brand and supply chain are growing issues for the pharmaceutical industry. Current estimates for counterfeit products range between 30% in a developing market, to in excess of 50% of product bought online! This problem will only grow as manufacture booms in Asia.
The reality is that an effective brand protection program must include investigation to be effective. Investigation activities achieve disruption and arrest of those involved in criminal importation and distribution of pharmaceuticals. The results are clear, as shown in our latest research report.
Read more about investigation within a brand protection program at the latest SMCS Risk Blog Post.